Celanese (NYSE:CE) Rating Maintained
In analysts note issued to clients and investors on Monday, 29 January, Celanese (NYSE:CE) stock Buy was reiterated by Analysts at Citigroup. They currently have a $128.0 target on the stock. Citigroup’s target would suggest a potential upside of 15.21 % from the company’s last stock close.
NYSE:CE is currently trading -0.30% lower at $104.03 as of 6:04 PM New York time. Celanese’s stock is 0% over the last 200 days. It has underperformed the S&P 500 Index, which has surged 6.00% over the same time period.
Out of 14 brokers covering Celanese, 6 rate it a Buy, 9 indicate a Hold while 1 suggest a Sell. The highest target is $82 and the lowest is $64 according to Thomson/First Call. The 12-month mean target is $76.79, which means downside potential of 26.18% over the current price.
Gmt Capital Corp had the biggest stake with ownership of 4.76M shares as of q2 2015 for 6.47% of the US equity exposure. Gavekal Capital Llc is another quite bullish institutional investor who is owning 141,558 shares of Celanese or 3.14% of their US equity exposure. Further, Lyrical Asset Management Lp have 3.14% of their US equity exposure invested in the company for 2.41M shares. The Pennsylvania-based fund Muhlenkamp & Co Inc revealed it had bought a stake worth about 3.11% of the institutional investor’s stock portfolio in Celanese. The New York-based fund Brown Brothers Harriman & Co is also positive about the stock, possessing 123,720 shares or 2.15% of their US equity exposure.
Celanese (NYSE:CE) Profile
Celanese Corporation (Celanese) is a technology and specialty materials company. The Company’s segments include Advanced Engineered Materials, Consumer Specialties, Industrial Specialties, Acetyl Intermediates and Other Activities. The Advanced Engineered Materials segment includes the Company’s engineered materials business and certain affiliates.
Celanese (NYSE:CE) traded down -0.30% on 29 January, hitting $104.03. A total of 1.05M shares of the company’s stock traded hands. This is up from average of 804,579 shares. Celanese has a 52 week low of $67.10 and a 52 week high of $109.11. The company has a market cap of $14.31B and a P/E ratio of 17.89.
Get the latest Celanese (NYSE:CE) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.
The post Celanese (NYSE:CE) Stock Buy Rating Reconfirmed at Citigroup; The Target Price is $128.0 appeared first on Octafinance.